Core Viewpoint - The stock of Shenguan Medical (300888.SZ) is currently in a state of decline, closing at 38.08 yuan with a drop of 3.57%, indicating it is below its initial public offering price [1] Group 1: Company Overview - Shenguan Medical was listed on the Shenzhen Stock Exchange's Growth Enterprise Market on September 17, 2020, with an issuance of 50 million shares at a price of 74.30 yuan per share [1] - The total funds raised by Shenguan Medical amounted to 3.715 billion yuan, with a net amount of 3.559 billion yuan after deducting issuance costs, which was 2.133 billion yuan more than the original plan [1] Group 2: Fund Utilization - The company initially planned to raise 1.426 billion yuan for projects including high-end dressing production line construction, marketing network development, research and development center establishment, and digital management system project [1] Group 3: Underwriting and Fees - The underwriting institution for Shenguan Medical's IPO was China International Capital Corporation, with representatives Shen Lulu and Wang Haonan, and the total issuance cost was 156 million yuan, of which the underwriting fee was 123 million yuan [1] Group 4: Dividend Distribution - On May 27, 2023, Shenguan Medical announced a cash dividend of 19.00 yuan (including tax) for every 10 shares, along with a capital increase of 4 shares for every 10 shares, based on a total of 419,737,649 shares after deducting repurchased shares [1]
稳健医疗跌3.57% 2020年上市超募21亿元